CRISPR Therapeutics AG

10-Q Quarter ended 2026-06-30 Aug 3, 2026 8-K Results of operations (earnings release) Aug 3, 2026 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jun 4, 2026 10-Q Quarter ended 2026-03-31 May 4, 2026 8-K Results of operations (earnings release) May 4, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Mar 16, 2026 8-K Other events Mar 11, 2026 10-K Fiscal year ended 2025-12-31 Feb 12, 2026 8-K Results of operations (earnings release) Feb 12, 2026 8-K Other events Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 8-K Other events Oct 15, 2025 10-Q Quarter ended 2025-06-30 Aug 4, 2025 8-K Results of operations (earnings release) Aug 4, 2025 8-K Other events Jun 26, 2025 8-K Amended charter or bylaws; Shareholder vote results Jun 9, 2025 8-K Entered a material agreement; Other events May 19, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 8-K Director or officer change Mar 26, 2025 10-K Fiscal year ended 2024-12-31 Feb 11, 2025 8-K Results of operations (earnings release) Feb 11, 2025 10-Q Quarter ended 2024-09-30 Nov 5, 2024 8-K Results of operations (earnings release) Nov 5, 2024 10-Q Quarter ended 2024-06-30 Aug 5, 2024 8-K Results of operations (earnings release) Aug 5, 2024 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jun 3, 2024 8-K Director or officer change May 23, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 10-K Fiscal year ended 2023-12-31 Feb 21, 2024 8-K Results of operations (earnings release) Feb 21, 2024 8-K Entered a material agreement Feb 13, 2024 8-K Other events Feb 13, 2024 8-K Other events Jan 16, 2024 8-K Director or officer change Dec 19, 2023 8-K Other events Dec 15, 2023 8-K Entered a material agreement Dec 13, 2023 8-K Other events Dec 8, 2023